Monitoring with mean kinetic temperature in GxP environments
Supplied by Vaisala Oyj on Tuesday, 14 February, 2017
Regulatory bodies in drug manufacturing and distribution have long been working together to create standards for temperature monitoring that will ensure the quality of drugs, devices and biotechnology. The mean kinetic temperature (MKT) value has been identified as a potential tool for evaluating the impact of temperature on product quality.
Download this paper to discover how to perform the calculation and some basic recommendations for its appropriate use.
Related White Papers
Streamlined set-up and access to multiple read-out options with PROTAC assays
Latest PROTAC advances raise the bar for oncology...
Leading pharma company delivers next-level quality and compliance — a case study
Discover how to easily monitor multiple...
Genomic DNA: extraction from whole blood
To find out how a DNA purification system isolates and purifies genomic DNA (gDNA) from whole...
